Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a **pseudogene** annotated as similar to a segment of the immunoglobulin heavy constant mu gene (IGHM). Unlike the IGHM gene, which encodes the constant region of the mu heavy chain found in IgM antibodies and plays an essential role in humoral immunity[2][3], this pseudogene does not encode a functional protein and is not involved in immune receptor activity. Pseudogenes are typically non-coding DNA segments that resemble functional genes but contain mutations or deletions that prevent protein expression. Thus, this entry is not considered a drug target, receptor, enzyme, transporter, or any functional therapeutic target. It is not associated with recognized therapeutic implications, disease mechanisms, or direct biomarkers. This gene is classified as a pseudogene due to sequence similarity with the functional IGHM gene, but it does not participate in antibody biosynthesis or immune signaling. NOTES: - The main functional gene is **Immunoglobulin heavy constant mu (IGHM)**, which is a bona fide therapeutic and diagnostic target—as opposed to the non-functional pseudogene referenced here[2][6]. - There is no evidence this specific pseudogene is expressed, therapeutically tractable, or relevant as a disease marker or safety risk in itself. - If your aim was the functional IgM target, instead use "Immunoglobulin heavy constant mu" (IGHM)[2][3][6]. - **is_incorrect = true** because pseudogenes are not considered therapeutic targets and returning it as a druggable receptor or enzyme would be factually incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to immunoglobulin heavy constant mu.